| 國立成功大學 |
2023 |
Firm location quality, founding family firms, and management team expertise
|
Chen, T.-K.;Tseng, Y.;Hsieh, Y.-T. |
| 臺大學術典藏 |
2022-04-01T08:53:09Z |
An international overview of national surveys for psychosocial hazards at work
|
Shiao J.S.-C.; Tseng Y.; Hsieh Y.-T.; Hou J.-Y.; YAWEN CHENG; Guo Y.L. |
| 臺大學術典藏 |
2022-03-31T09:04:32Z |
Assaults against nurses of general and psychiatric hospitals in Taiwan
|
Shiao J.S.-C.; Tseng Y.; Hsieh Y.-T.; Hou J.-Y.; Cheng Y.; YUE-LIANG GUO |
| 臺大學術典藏 |
2021-09-02T00:09:06Z |
Mixed-Cell-Height Placement with Drain-to-Drain Abutment and Region Constraints
|
Chen J;Zhu Z;Guo L;Tseng Y;Chang Y.; Chen J; Zhu Z; Guo L; Tseng Y; Chang Y.; YAO-WEN CHANG |
| 臺大學術典藏 |
2021-08-31T06:42:27Z |
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
|
Ghamande S.; Lin C.-C.; Cho D.C.; Shapiro G.I.; Kwak E.L.; Silverman M.H.; Tseng Y.; Kuo M.-W.; Mach W.B.; Hsu S.-C.; Coleman T.; Yang J.C.-H.; ANN-LII CHENG; Ghalib M.H.; Chuadhary I.; Goel S. |
| 臺大學術典藏 |
2020-11-03T11:57:02Z |
UB-311, a novel UBITh? amyloid β peptide vaccine for mild?Alzheimer's?disease
|
Wang C.Y.; Wang P.-N.; Ming-Jang Chiu; Finstad C.L.; Lin F.; Lynn S.; Tai Y.-H.; De Fang X.; Zhao K.; Hung C.-H.; Tseng Y.; Peng W.-J.; Wang J.; Yu C.-C.; Kuo B.-S.; Frohna P.A.; Wang C.Y.; MING-JANG CHIU et al. |
| 臺大學術典藏 |
2020-07-24T03:43:17Z |
P-CSI v1.0, an accelerated barotropic solver for the high-resolution ocean model component in the Community Earth System Model v2.0
|
Bryan, F.O.; Dennis, J.; Fu, H.; Yang, G.; YU-HENG TSENG; Baker, A.H.; Hu, Y.; Tseng, Y.; Huang, X.;Tang, Q.;Tseng, Y.;Hu, Y.;Baker, A.H.;Bryan, F.O.;Dennis, J.;Fu, H.;Yang, G.; Huang, X.; Tang, Q. |
| 臺大學術典藏 |
2020-05-26T09:27:00Z |
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
|
Ghamande S; Lin C.-C; Cho D.C; Shapiro G.I; Kwak E.L; Goel S.; Chuadhary I; Ghalib M.H; Cheng A.-L; CHIH-HSIN YANG; Coleman T; Silverman M.H; Tseng Y; Kuo M.-W; Mach W.B; Hsu S.-C |
| 臺大學術典藏 |
2020-05-25T07:35:23Z |
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
|
Ghamande S; Chia-Chi Lin; Cho D.C; Shapiro G.I; Kwak E.L; Silverman M.H; Tseng Y; Kuo M.-W; Mach W.B; Hsu S.-C; Coleman T; Yang J.C.-H; Cheng A.-L; Ghalib M.H; Chuadhary I; Goel S. |
| 臺大學術典藏 |
2020-05-04T08:21:18Z |
4D-QSAR Analysis of a Series of Antifungal P450 Inhibitors and 3D-Pharmacophore Comparisons as a Function of Alignment
|
YUFENG JANE TSENG; Yufeng Jane TsengLiu, J.;Pan, D.;Tseng, Y.;Hopfinger, A.J.; Liu, J.; Pan, D.; Tseng, Y.; Hopfinger, A.J. |
